Journals / Erciyes Medical Journal / 2017 / Cilt: 39 - Sayı: 1

An Important Question That Needs to Be Proved: Is There Any Relationship between the Epicardial Fat Thickness and the Coronary Artery Complexity in Patients with Acute Non-ST Elevation Myocardial Infarction?

Pages
16–23
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, no correlation was demonstrated between EFT and NLR (r=0.081, p=0.145) in patients with NSTEMI.Conclusion: These results showed that EFT is significantly associated with coronary artery lesion complexity in patients with NSTEMI and can work as a risk marker in these patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In this study, we aimed to investigate the association of epicardial fat thickness (EFT) and coronary artery lesion complexity with patients having acute non-ST elevation myocardial infarction (NSTEMI).Materials and Methods: The patients (n=328) were divided into low syntax score (SS) group (SS<=17; Low-SSG), intermediate SS group (SS=18-28; In-SSG), and high SS group (SS>=29; High-SSG) based on the SS value.
📊
Key Findings & Data:EFT was measured by transthoracic echocardiography and was recorded on a digital storage device.Results: High-SSG had a significantly higher mean of EFT (6.65±0.82 mm) when compared to Low-SSG (5.12±1.13 mm) and In-SSG (5.79±0.83 mm) (p<0.001).
💡
Conclusion & Impact:However, no correlation was demonstrated between EFT and NLR (r=0.081, p=0.145) in patients with NSTEMI.Conclusion: These results showed that EFT is significantly associated with coronary artery lesion complexity in patients with NSTEMI and can work as a risk marker in these patients.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: In this study, we aimed to investigate the association of epicardial fat thickness (EFT) and coronary artery lesion complexity with patients having acute non-ST elevation myocardial infarction (NSTEMI).Materials and Methods: The patients (n=328) were divided into low syntax score (SS) group (SS<=17; Low-SSG), intermediate SS group (SS=18-28; In-SSG), and high SS group (SS>=29; High-SSG) based on the SS value. EFT, SS, distributions of the critical coronary artery lesions, and the neutrophil-lymphocyte ratio (NLR) wsi, Kardiyoloji Kliniği, İstanbul, Türkiyeere determined for all the groups. EFT was measured by transthoracic echocardiography and was recorded on a digital storage device.Results: High-SSG had a significantly higher mean of EFT (6.65±0.82 mm) when compared to Low-SSG (5.12±1.13 mm) and In-SSG (5.79±0.83 mm) (p<0.001). EFT showed a significant positive correlation with SS (r=0.607, p<0.001). Further, a significant positive correlation was revealed with the distributions of critical coronary artery lesions of the left anterior descending (LAD), circumflex artery (Cx), and right coronary artery (RCA) (r=0.260, p<0.001; r=0.213, p=0.001; and r=0.275, p<0.001, respectively). However, no correlation was demonstrated between EFT and NLR (r=0.081, p=0.145) in patients with NSTEMI.Conclusion: These results showed that EFT is significantly associated with coronary artery lesion complexity in patients with NSTEMI and can work as a risk marker in these patients.

🔖

Cite This Article

KARAKURT, A., YILDIZ, C. (2017). An Important Question That Needs to Be Proved: Is There Any Relationship between the Epicardial Fat Thickness and the Coronary Artery Complexity in Patients with Acute Non-ST Elevation Myocardial Infarction?. Erciyes Medical Journal, Cilt: 39 - Sayı: 1, 16–23. https://ajindex.com/articles/223486

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983
  2. 67(5): 968-77. [CrossRef] Despres JP. Body fat distribution and risk of cardiovascular disease: an update. Circulation 2012
  3. 126(10): 1301-13. [CrossRef] Iacobellis G, Corradi D, Sharma AM. Epicardial adipose tissue: ana- tomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med 2005
  4. 2(10): 536-43. [CrossRef] Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Cir- culation 2002
  5. 105(9): 1135-43. [CrossRef] Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H, et al. Human epicardial adipose tissue is a source of inflammatorymedia- tors. Circulation 2003
  6. 108(20): 2460-6. [CrossRef] Baker AR, Silva NF, Quinn DW, Harte AL, Pagano D, Bonser RS, et al. Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol 2006
  7. [CrossRef] Cheng KH, Chu CS, Lee KT, Lin TH, Hsieh CC, Chiu CC, et al. Adipocytokines and proinflammatory mediators from abdominal and epicardial adipose tissue in patients with coronary artery disease. Int J Obes (Lond) 2008
  8. 32(2): 268-74. [CrossRef] Iacobellis G, Pistilli D, Gucciardo M, Leonetti F, Miraldi F, Brancaccio G, et al. Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease. Cytokine 2005
  9. 29(6): 251-5. [CrossRef] Teijeira-Fernandez E, Eiras S, Salgado Somoza A, Gonzalez-Juanatey JR. Baseline epicardial adipose tissue adiponectin levels predict car- diovascular outcomes: a long-term follow-up study. Cytokine 2012
  10. 60(3): 674-80. [CrossRef] Keophiphath M, Achard V, Henegar C, Rouault C, Clément K, Lacasa D. Macrophage-secreted factors promote a profibrotic phenotype in human preadipocytes. Mol Endocrinol 2009
  11. 23(1): 11-24. [CrossRef] Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005
  12. 112(17): 2735-52. [CrossRef] Sharma AM. Adipose tissue: a mediator of cardiovascular risk. Int J Obes Relat Metab Disord 2002
  13. 26(4): 5-7. [CrossRef] Sacks HS, Fain JN. Human epicardial adipose tissue: a review. Am Heart J 2007
  14. 153(6): 907-17. [CrossRef] Iozzo P. Myoc